Guardion Health Sciences

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$72
$2,999
$2,935
$3,337
Gross Profit
36
1,179
1,344
1,460
EBITDA
-1,362
-1,015
-687
-1,818
EBIT
-1,367
-1,020
-692
-1,823
Net Income
-1,932
-4,746
424
372
Net Change In Cash
72
2,999
2,935
3,337
Free Cash Flow
-1,080
-754
-1,317
-766
Cash
14,822
5,605
6,359
7,657
Basic Shares
1,284
1,280
1,275
1,273

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$12,248
$11,049
$7,233
$1,889
Gross Profit
5,375
4,520
3,110
-56
EBITDA
-3,922
1,681
-9,574
-8,282
EBIT
-3,941
432
-10,484
-8,502
Net Income
158
-30,277
-24,745
-8,578
Net Change In Cash
12,248
11,049
7,233
1,889
Cost of Revenue
-2,596
Free Cash Flow
-4,373
-7,452
-10,719
-8,054
Cash
6,359
10,655
4,093
8,518
Basic Shares
1,270
1,121
473
47

Earnings Calls

Quarter EPS
2024-06-30
$8.03
2024-03-31
-$3.71
2023-12-31
$0.65
2023-09-30
$0.29